However the results are puzzling as so much research has shown that the widespread usage of mammograms have produced early recognition of breast malignancy more common and reduced death rates from the disease. The study found declines among groups who traditionally have used mammography at high rates, including higher-income and better-educated ladies, those in age range 50 to 64 and non-Hispanic whites. Dr. Breen says the results were based on a scientific survey of about 10,000 U.S. Females 40 and older by the Centers for Disease Prevention and Control. Malignancy charities say the trend may lead to more breast cancer deaths. Breast tumor is the second leading reason behind cancer death in ladies and in the United States, an estimated 178,000 women will be diagnosed with breast cancer this year and about 40,000 will die from it.This study is being conducted at Detroit Receiving Hospital, Detroit, MI. A total of 47 patients> All patients getting Cardene I.V. Achieved target BP by a day, as compared to just 15 who received labetalol , with a greater proportion of sufferers on Cardene We significantly.V. Achieving their focus on BP within one hour of starting treatment than those treated with labetalol . During the 24-hour study, patients getting Cardene I.V. Had been within the target BP range for 82.6) of that time period compared to 48.0) of the right time for labetalol patients. Additional antihypertensive brokers were required by 0 percent of the Cardene I.V. Sufferers and by 73 percent of the labetalol patients. There was no significant difference between treatments in the incidence of bradycardia, tachycardia, or hypotension.